Public Offering to Net a Cool $40M for ArQule
By Catherine Shaffer
Friday, January 21, 2011
ArQule Inc. priced a public offering of 7 million shares of common stock at $6.15 per share to boost research and development of its pipeline of cancer products. The offering, which is expected to close Jan. 25, grants underwriters a 30-day option to purchase up to 1.05 million additional shares to cover overallotments.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.